share_log

AbbVie | 144: Notice of proposed sale of securities pursuant to Rule 144

SEC announcement ·  Mar 18 17:07
Summary by Moomoo AI
AbbVie Inc. officer Stewart Jeffrey Ryan is set to sell 58,949 common shares of the company on March 18, 2024, with an aggregate market value of approximately $10,539,878. The shares to be sold were acquired through stock option exercises and performance shares, both as compensation from the issuer. On March 18, 2024, Ryan acquired 26,110 shares via stock option exercise, and on February 28, 2024, he acquired 32,839 shares as performance shares. There is no reportable history of securities sold in the past three months prior to this notice.
AbbVie Inc. officer Stewart Jeffrey Ryan is set to sell 58,949 common shares of the company on March 18, 2024, with an aggregate market value of approximately $10,539,878. The shares to be sold were acquired through stock option exercises and performance shares, both as compensation from the issuer. On March 18, 2024, Ryan acquired 26,110 shares via stock option exercise, and on February 28, 2024, he acquired 32,839 shares as performance shares. There is no reportable history of securities sold in the past three months prior to this notice.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more